期刊
JOURNAL OF MOLECULAR NEUROSCIENCE
卷 54, 期 4, 页码 739-747出版社
HUMANA PRESS INC
DOI: 10.1007/s12031-014-0356-x
关键词
Alzheimer's disease; CSF; Blood; Biomarker; Proteomics
Alzheimer's disease (AD) is a common neurodegenerative disease. Although early diagnosis of AD is challenging, identification and treatment at the preclinical stage is critical for preventing the severe and irreversible damage to neurons. Thus, during the last few decades, many researchers have sought efficient biomarkers for early diagnosis of AD, monitoring disease progression, and gauging responses to therapies. Recently, various molecular markers have been investigated in blood, plasma, cerebrospinal fluid, and other body fluids. This review summarizes the results of some recent studies that searched for biomarkers of AD in cerebrospinal fluid (CSF) and blood.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据